Latest Publication

Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases

Meenakshi Malhotra, Catherine Tomaro-Duchesneau, Satya Prakash*

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA

Meenakshi Malhotra1 Catherine Tomaro-Duchesneau1 Shyamali Saha2 Imen Kahouli3 Satya Prakash1

A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications

Ahmed Khaled Abosalha, Waqar Ahmad, Jacqueline Boyajian, Paromita Islam, Merry Ghebretatios, Sabrina Schaly, Rahul Thareja, Karan Arora & Satya Prakash

Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells

Meenakshi Malhotra, Arun Kulamarva, Safaa Sebak, Arghya Paul, Jasmine Bhathena, Maryam Mirzaei and Satya Prakash

Clinical pharmacology of siRNA therapeutics: current status and future prospects

Ahmed Khaled Abosalha, Jacqueline Boyajian, Waqar Ahmad, Paromita Islam, Merry Ghebretatios, Sabrina Schaly, Rahul Thareja, Karan Arora & Satya Prakash

PLK1, A Potential Target for Cancer Therapy Zhixian Liu*, Qingrong Sun† and Xiaosheng Wang*

*Department of Basic Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China; †School of Science, China Pharmaceutical University, Nanjing 211198, China

Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer

MeenakshiMalhotra,1 Catherine Tomaro-Duchesneau,1 Shyamali Saha,1,2 and Satya Prakash1

Nanora Pharma is at the forefront of pharmaceutical innovation, dedicated to developing advanced treatments that improve lives worldwide. Our passion for science and commitment to health drive us to deliver groundbreaking solutions for today’s medical challenges.

Site Links

Follow Us

© 2026  Powered by Nanora Pharma